Skip to main content
. Author manuscript; available in PMC: 2022 Mar 29.
Published in final edited form as: Biomed Pharmacother. 2020 Aug 21;130:110596. doi: 10.1016/j.biopha.2020.110596

Fig. 4.

Fig. 4.

Rates of mortality and re-hospitalization for heart failure in patients treated with angiotensin receptor neprilysin inhibitor (ARNI) or standard optimal medical treatment (OMT).